Abstract
The birth and death of a pandemic can be region specific. Pandemic seems to make repeated appearance in some places which is often attributed to human neglect and seasonal change. However, difference could arise from different distributions of inherent susceptibility (σinh) and external infectivity (ιext) from one population to another. These are often ignored in the theoretical treatments of an infectious disease progression. While the former is determined by the immunity of an individual towards a disease, the latter depends on the duration of exposure to the infection. Here we model the spatio-temporal propagation of a pandemic using a generalized SIR (Susceptible-Infected-Removed) model by introducing the susceptibility and infectivity distributions to comprehend their combined effects. These aspects have remained inadequately addressed till date. We consider the coupling between σinh and ιext through a new critical infection parameter (γc). We find that the neglect of these distributions, as in the naive SIR model, results in an overestimation in the estimate of the herd immunity threshold. That is, the presence of the distributions could dramatically reduce the rate of spread. Additionally, we include the effects of long-range migration by seeding new infections in a region. We solve the resulting master equations by performing Kinetic Monte Carlo Cellular Automata (KMC-CA) simulations. Importantly, our simulations can reproduce the multiple infection peak scenario of a pandemic. The latent interactions between disease migration and the distributions of susceptibility and infectivity can render the progression a character vastly different from the naive SIR model. In particular, inclusion of these additional features renders the problem a character of a living percolating system where the disease cluster can survive by spatial migration.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Science and Engineering Research Board, DST India. National Science Chair Professorship, India. Indian Institute of Science, Bengaluru, Karnataka, India
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our institute (IISc Bengaluru) does not require or provide IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.